Your browser doesn't support javascript.
loading
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme.
Maianti, Juan Pablo; Tan, Grace A; Vetere, Amedeo; Welsh, Amie J; Wagner, Bridget K; Seeliger, Markus A; Liu, David R.
Afiliação
  • Maianti JP; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Tan GA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Vetere A; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Welsh AJ; Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wagner BK; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
  • Seeliger MA; Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Liu DR; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Nat Chem Biol ; 15(6): 565-574, 2019 06.
Article em En | MEDLINE | ID: mdl-31086331
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metaloproteases / Inibidores Enzimáticos / Bibliotecas de Moléculas Pequenas / Insulina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metaloproteases / Inibidores Enzimáticos / Bibliotecas de Moléculas Pequenas / Insulina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article